Literature DB >> 28769199

IN VITRO COMPARATIVE ACTIVITY OF EIGHT ANTIPSEUDOMONAL AGENTS.

G S Chopra1, S S Gill2, S K Basu3.   

Abstract

Five hundred and thirty strains of Pseudomonas aeruginosa isolated from indoor patients were tested against three chemical groups comprising eight antibiotics. High degree of resistant strains ranging from 38.0% to 61.8% were seen against carbenicillin, piperacillin and gentamicin. However amikacin, ciprofloxacin, ceftazidime, netilmicin and norfloxacin showed comparatively better activity with resistant strains ranging from 7.8% to 22.8%. A notably higher rate of resistance was seen in urinary isolates.

Entities:  

Keywords:  Aminoglycosides; Beta-lactams; Pseudomonas; Quinolones

Year:  2017        PMID： 28769199      PMCID： PMC5529726          DOI： 10.1016/S0377-1237(17)31058-4

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


  7 in total

1.  Quinolone/ureidopenicillin cross-resistance.

Authors:  L J Piddock; W J Wijnands; R Wise
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

2.  Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients.

Authors:  A L Baltch; P E Griffin
Journal:  Am J Med Sci       Date:  1977 Sep-Oct       Impact factor: 2.378

3.  Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.

Authors:  K Hirai; H Aoyama; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

4.  In-vitro susceptibility of nosocomial gram-negative bloodstream pathogens to quinolones and other antibiotics--a statistical approach.

Authors:  M A Martin; M A Pfaller; P B Rojas; R F Woolson; R P Wenzel
Journal:  J Antimicrob Chemother       Date:  1989-03       Impact factor: 5.790

5.  Activity of antibiotics against resistant Pseudomonas aeruginosa.

Authors:  J Fujita; K Negayama; K Takigawa; Y Yamagishi; A Kubo; Y Yamaji; J Takahara
Journal:  J Antimicrob Chemother       Date:  1992-05       Impact factor: 5.790

Review 6.  Xanthomonas maltophilia: an emerging nosocomial pathogen.

Authors:  W F Marshall; M R Keating; J P Anhalt; J M Steckelberg
Journal:  Mayo Clin Proc       Date:  1989-09       Impact factor: 7.616

7.  Antimicrobial resistance among gram-negative bacilli to newer aminoglycosides and beta-lactams.

Authors:  S Jain; R Sarkar
Journal:  Indian J Pathol Microbiol       Date:  1991-10       Impact factor: 0.740
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.